BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23237912)

  • 1. A case of long QT syndrome with triple gene abnormalities: digenic mutations in KCNH2 and SCN5A and gene variant in KCNE1.
    Yoshikane Y; Yoshinaga M; Hamamoto K; Hirose S
    Heart Rhythm; 2013 Apr; 10(4):600-3. PubMed ID: 23237912
    [No Abstract]   [Full Text] [Related]  

  • 2. Long QT and Brugada syndrome gene mutations in New Zealand.
    Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
    Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic dropout in long QT syndrome genetic testing: a possible mechanism underlying false-negative results.
    Tester DJ; Cronk LB; Carr JL; Schulz V; Salisbury BA; Judson RS; Ackerman MJ
    Heart Rhythm; 2006 Jul; 3(7):815-21. PubMed ID: 16818214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation Analysis of KCNQ1, KCNH2 and SCN5A Genes in Taiwanese Long QT Syndrome Patients.
    Chang YS; Yang YW; Lin YN; Lin KH; Chang KC; Chang JG
    Int Heart J; 2015; 56(4):450-3. PubMed ID: 26118593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA-based diagnostics of long QT syndrome].
    Berge KE; Haugaa KH; Anfinsen OG; Früh A; Hallerud M; Jonsrud C; Øyen N; Gjesdal K; Amlie JP; Leren TP
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2783-6. PubMed ID: 16244680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2.
    Christiansen M; Hedley PL; Theilade J; Stoevring B; Leren TP; Eschen O; Sørensen KM; Tybjærg-Hansen A; Ousager LB; Pedersen LN; Frikke-Schmidt R; Aidt FH; Hansen MG; Hansen J; Bloch Thomsen PE; Toft E; Henriksen FL; Bundgaard H; Jensen HK; Kanters JK
    BMC Med Genet; 2014 Mar; 15():31. PubMed ID: 24606995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases.
    Winkel BG; Larsen MK; Berge KE; Leren TP; Nissen PH; Olesen MS; Hollegaard MV; Jespersen T; Yuan L; Nielsen N; Haunsø S; Svendsen JH; Wang Y; Kristensen IB; Jensen HK; Tfelt-Hansen J; Banner J
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1092-8. PubMed ID: 22882672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of patients with congenital long QT syndrome and bigenic mutations.
    Jimmy JJ; Chen CY; Yeh HM; Chiu WY; Yu CC; Liu YB; Tsai CT; Lo LW; Yeh SF; Lai LP
    Chin Med J (Engl); 2014; 127(8):1482-6. PubMed ID: 24762593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common Variants in
    Vatta M; Truty R; Garcia J; Callis TE; Hatchell K; Rojahn S; Morales A; Aradhya S; Nussbaum R
    Circ Genom Precis Med; 2021 Feb; 14(1):e003206. PubMed ID: 33517668
    [No Abstract]   [Full Text] [Related]  

  • 10. Cascade screening in families with inherited cardiac diseases driven by cardiologists: feasibility and nationwide outcome in long QT syndrome.
    Theilade J; Kanters J; Henriksen FL; Gilså-Hansen M; Svendsen JH; Eschen O; Toft E; Reimers JI; Tybjærg-Hansen A; Christiansen M; Jensen HK; Bundgaard H
    Cardiology; 2013; 126(2):131-7. PubMed ID: 23969902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance.
    Barc J; Briec F; Schmitt S; Kyndt F; Le Cunff M; Baron E; Vieyres C; Sacher F; Redon R; Le Caignec C; Le Marec H; Probst V; Schott JJ
    J Am Coll Cardiol; 2011 Jan; 57(1):40-7. PubMed ID: 21185499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between congenital long QT syndrome and Brugada syndrome gene mutation].
    Du R; Ren FX; Yang JG; Yuan GH; Zhang SY; Kang CL; Li W; Gui L; Li J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):289-94. PubMed ID: 16038262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population.
    Gouas L; Nicaud V; Berthet M; Forhan A; Tiret L; Balkau B; Guicheney P;
    Eur J Hum Genet; 2005 Nov; 13(11):1213-22. PubMed ID: 16132053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [KCNQ1, KCNH2, KCNE1 and KCNE2 potassium channels gene variants in sudden manhood death syndrome].
    Zhao QH; Liu C; Lu LW; Lü GL; Liu H; Tang SB; Quan L; Cheng JD
    Fa Yi Xue Za Zhi; 2012 Oct; 28(5):337-41, 346. PubMed ID: 23213782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.
    Paulussen AD; Gilissen RA; Armstrong M; Doevendans PA; Verhasselt P; Smeets HJ; Schulze-Bahr E; Haverkamp W; Breithardt G; Cohen N; Aerssens J
    J Mol Med (Berl); 2004 Mar; 82(3):182-8. PubMed ID: 14760488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutations.
    Trolle C; Mortensen KH; Pedersen LN; Berglund A; Jensen HK; Andersen NH; Gravholt CH
    PLoS One; 2013; 8(7):e69614. PubMed ID: 23936059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation screening in KCNQ1, HERG, KCNE1, KCNE2 and SCN5A genes in a long QT syndrome family.
    Koo SH; Teo WS; Ching CK; Chan SH; Lee EJ
    Ann Acad Med Singap; 2007 Jun; 36(6):394-8. PubMed ID: 17597962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphism map of five long-QT genes.
    Aydin A; Bähring S; Dahm S; Guenther UP; Uhlmann R; Busjahn A; Luft FC
    J Mol Med (Berl); 2005 Feb; 83(2):159-65. PubMed ID: 15599693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics.
    Terrenoire C; Wang K; Tung KW; Chung WK; Pass RH; Lu JT; Jean JC; Omari A; Sampson KJ; Kotton DN; Keller G; Kass RS
    J Gen Physiol; 2013 Jan; 141(1):61-72. PubMed ID: 23277474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.